Outcome and treatment quality of transfer primary percutaneous intervention in older patients with acute ST-elevation myocardial infarction (STEMI)

Archives of Gerontology and Geriatrics

Volumn 53, Issue 3, 2011, Pages

  Birkemeyer, Ralf ^a   Rillig, Andreas ^a   Treusch, Fabian ^a   Kunze, Markus ^a   Meyerfeldt, Udo ^a   Miljak, Tomislav ^a   Kostin, Daniel ^a   Koch, Annette ^a   Jung, Werner ^a   Oster, Peter ^b   Bahrmann, Anke ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute coronary syndrome (ACS); Acute ST elevation myocardial infarction (STEMI); Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; CREATINE KINASE; CREATINE KINASE MB;

ACUTE HEART INFARCTION; AGE; AGED; AGING; ANEURYSM; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; CLINICAL TRIAL; CREATINE KINASE BLOOD LEVEL; DRUG ELUTING STENT; FEMALE; FEMORAL ARTERY ANEURYSM; HEART REINFARCTION; HUMAN; KIDNEY FAILURE; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAIN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT; THERAPY DELAY; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HOSPITAL COMMUNICATION SYSTEMS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT CARE TEAM; PATIENT TRANSFER; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958849245     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2010.11.015     Document Type: Article

References (20)

1. Alexander K.P., Newby L.K., Armstrong P.W., Cannon C.P., Gibler W.B., Rich M.W., Van de Werf F., White H.D., Weaver W.D., Naylor M.D., Gore J.M., Krumholz H.M., Ohman E.M. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007, 115:2570-2589. American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology.
2. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Ornato J.P., Pearle D.L., Sloan M.A., Smith S.C. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial Infarction). J. Am. Coll. Cardiol. 2004, 44:671-719. American College of Cardiology; American Heart Association; Canadian Cardiovascular Society.
3. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 1987, 40:373-383.
4. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., Ludbrook P., Markis J.E., Mueller H., Passa-mani E.R., Powers E.R., Rao A.K., Robertson T., Ross A., Ryan T.J., Sobel B.E., Willerson J., Williams D.O., Zaret B.L., Braunwald E. Thrombo-lysis In Myocardial Infarction (TIMI) Trial. Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987, 76:142-154.
5. Chirinos J.A., Veerani A., Zambrano J.P., Schob A., Perez G., Mendez A.J., Chakko S. Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease. Int. J. Cardiol. 2007, 117:97-102.
6. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
7. Dzavik V., Sleeper L.A., Cocke T.P., Moscucci M., Saucedo J., Hosat S., Jiang X., Slater J., LeJemtel T., Hochman J.S. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur. Heart J. 2003, 24:828-837. SHOCK Investigators.
8. Eagle K.A., Goodman S.G., Avezum A., Budaj A., Sullivan C.M., López-Sendón J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002, 359:373-377. GRACE Investigators.
9. Goldberg R.J., Yarzebski J., Lessard D., Gore J.M. Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack Study. Arch. Intern. Med. 2000, 160:3217-3223.
10. Krumholz H.M., Friesinger G.C., Cook E.F., Lee T.H., Rouan G.W., Goldman L. Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction. J. Am. Geriatr. Soc. 1994, 42:127-131.
11. Mehta R.H., Rathore S.S., Radford M.J., Wang Y., Wang Y., Krumholz H.M. Acute myocardial infarction in the elderly: differences by age. J. Am. Coll. Cardiol. 2001, 38:736-741.
12. Merlini P.A., Rossi M., Menozzi A., Buratti S., Brennan D.M., Moliterno D.J., Topol E.J., Ardissino D. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation 2004, 109:2203-2206.
13. Motivala A.A., Tamhane U., Saab F., Li J., Rogers E.K., Froehlich J., Moscucci M., Eagle K.A., Gurm H.S. Temporal trends in antiplatelet/antithrombotic use in acute coronary syndromes and in-hospital major bleeding complications. Am. J. Cardiol. 2007, 100:1359-1363.
14. Renal Association Chronic Kidney Disease in Adults 2006, UK Guidelines for Identification, Management and Referral, RA, London.
15. Schoenenberger A.W., Radovanovic D., Stauffer J.C., Windecker S., Urban P., Eberli F.R., Stuck A.E., Gutzwiller F., Erne P. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study. J. Am. Geriatr. Soc. 2008, 56:510-516. Acute Myocardial Infarction in Switzerland Plus Investigators.
16. Schömig A., Mehilli J., Antoniucci D., Ndrepepa G., Markwardt C., Di Pede F., Nekolla S.G., Schlotterbeck K., Schühlen H., Pache J., Seyfarth M., Martinoff S., Benzer W., Schmitt C., Dirschinger J., Schwaiger M., Kastrati A. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12hours from symptom onset: a randomized controlled trial. J. Am. Med. Assoc. 2005, 293:2865-2872. Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators.
17. Stone G.W., Grines C.L., Browne K.F., Marco J., Rothbaum D., O'Keefe J., Hartzler G.O., Overlie P., Donohue B., Chelliah N. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J. Am. Coll. Cardiol. 1995, 25:370-377.
18. The Joint European Society of Cardiology/American College of Cardiology Committee Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology for the redefinition of myocardial infarction. Eur. Heart J. 2000, 21:1502-1513.
19. White H.D., Barbash G.I., Califf R.M., Simes R.J., Granger C.B., Weaver W.D., Kleiman N.S., Aylward P.E., Gore J.M., Vahanian A., Lee K.L., Ross A.M., Topol E.J. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial: global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 1996, 94:1826-1833.
20. Yarzebski J., Goldberg R.J., Gore J.M., Alpert J.S. Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. Am. Heart J. 1994, 128:255-263.